CV Sciences, Inc. Applauds USDA’s Establishment of the U.S. Domestic Hemp Production Program
Program Creates a Consistent Regulatory Framework for Hemp Production Throughout the United States.
Read More
Category: US Stocks
NewLeaf Brands & Wholly Owned Subsidiary Fresh Water CBD, LLC Announces New & Improved Formulation, Increased Potency and Product Redesign
The new designs will decrease overall production costs and keep the CBD more sustainable.
Read More
KALY – Kali-Extracts Entertains $50 Million Cannabis Biopharmaceutical Technology Acquisition Valuation
The valuation has been presented to KALY by an investor interested in acquiring KALY’s U.S. Patented Cannabis Extraction Process.
Read More
Cara Therapeutics to Announce Third Quarter 2019 Financial Results on November 5, 2019
Cara Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus.
Read More
CV Sciences, Inc. Appoints Beth Altman to its Board of Directors
The company announced the appointment of Beth Altman to its Board of Directors effective October 24, 2019.
Read MoreGET LISTED
